» Articles » PMID: 17688387

Drug-induced Photoallergic and Phototoxic Reactions

Overview
Specialty Pharmacology
Date 2007 Aug 11
PMID 17688387
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Drug-induced photosensitivity involves reactions to medication triggered by exposure of the skin to ultraviolet light. Medications that trigger reactions can be topical or oral. Following interaction of ultraviolet radiation with a chemical present in sufficient amounts in the skin, one of the several reactions may occur in susceptible patients, most commonly photoallergy or phototoxicity. These reactions can be diagnosed separately based on pathogenesis, clinical characteristics and histopathology. Phototoxic disorders have a higher incidence than photoallergic disorders. The action spectra for most photoallergens and phototoxins lie in the ultraviolet A range. Subtypes of drug-induced photosensitivity include dyschromia, pseudoporphyria, photo onycholysis, and lichenoid and telangiectatic reactions.

Citing Articles

Modulation of the photobehavior of gefitinib and its phenolic metabolites by human transport proteins.

Tamarit L, El Ouardi M, Lence E, Andreu I, Gonzalez-Bello C, Miranda M Front Pharmacol. 2024; 15:1387057.

PMID: 38818381 PMC: 11137198. DOI: 10.3389/fphar.2024.1387057.


Tolerability of Narrow-band Ultraviolet-B Phototherapy for Different Dermatological Diseases in Relation to Co-medications.

Halupczok A, Bohne A, Gerdes S, Weidinger S, Weichenthal M Acta Derm Venereol. 2024; 104:adv35215.

PMID: 38567914 PMC: 11005185. DOI: 10.2340/actadv.v104.35215.


Antineoplastic drugs-related medication-associated pseudoporphyria.

Cohen P JAAD Case Rep. 2023; 42:66-68.

PMID: 38077162 PMC: 10700850. DOI: 10.1016/j.jdcr.2023.08.019.


Switching from ultrafast electron transfer to proton transfer in excited drug-protein complexes upon biotransformation.

Tamarit L, El Ouardi M, Lence E, Andreu I, Gonzalez-Bello C, Vaya I Chem Sci. 2022; 13(33):9644-9654.

PMID: 36091919 PMC: 9400592. DOI: 10.1039/d2sc03257k.


Photoprocesses of the tyrosine kinase inhibitor gefitinib: from femtoseconds to microseconds and from solution to cells.

Tamarit L, El Ouardi M, Andreu I, Vaya I, Miranda M Chem Sci. 2021; 12(36):12027-12035.

PMID: 34667568 PMC: 8457384. DOI: 10.1039/d1sc03154f.